Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation.
Baek DW, Moon JH, Lee JH, Kang KW, Lee HS, Eom HS, Lee E, Lee JH, Lee JO, Park SK, Kim SJ, Yoo KH, Yoon SS, Koh Y, Kang HJ, Won JH, Lyu CJ, Hahn SM, Lee JH, Park JS, Jo JC, Mun YC, Yang DH, Song GY, Lim SN, Sohn SK; Korean Society of Blood and Marrow Transplantation.
Baek DW, et al. Among authors: hahn sm.
Blood Cancer J. 2023 Jun 26;13(1):95. doi: 10.1038/s41408-023-00868-w.
Blood Cancer J. 2023.
PMID: 37365207
Free PMC article.
Overall, 96 (51.1%) patients underwent auto-SCT and 92 (48.9%) patients underwent allo-SCT. Auto-SCT improved long-term survival in patients with complete remission (CR). Allo-SCT demonstrated better 3-year PFS in patients with partial remission and relapsed/refractory dis …
Overall, 96 (51.1%) patients underwent auto-SCT and 92 (48.9%) patients underwent allo-SCT. Auto-SCT improved long-term survival in p …